NCT03308526

Brief Summary

Prevailing microorganisms causing neonatal sepsis in neonatal intensive care unit of Assiut University children Hospital Methods prospective study conducted in the neonatal intensive care unit in Assiut university children hospital.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2017

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 12, 2017

Completed
20 days until next milestone

Study Start

First participant enrolled

November 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

October 12, 2017

Status Verified

September 1, 2017

Enrollment Period

1 year

First QC Date

October 8, 2017

Last Update Submit

October 8, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevention of neonatal sepsis

    Recognition of prevailing microorganisms causing neonatal sepsis in neonatal intensive care units to take preventive measures against it to decrease the incidence of neonatal sepsis

    From september2017 to september 2018

Eligibility Criteria

AgeUp to 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Neonates from age zero to 28 days

You may qualify if:

  • both preterm and full term neonates
  • both early onset and late onset neonatal sepsis

You may not qualify if:

  • Genetic diseases immunocompromized neonates
  • Neonates of diabetic mothers
  • Neonates of HIV mothers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neonatal Sepsis

Condition Hierarchy (Ancestors)

SepsisInfectionsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal invistigator

Study Record Dates

First Submitted

October 8, 2017

First Posted

October 12, 2017

Study Start

November 1, 2017

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

October 12, 2017

Record last verified: 2017-09